Spatial multi‐omics unveils sphingolipid metabolic reprogramming within the retinal pathological niche
iMeta · 2026-08 · 5 (4)
DOI: 10.1002/imt2.70163 ↗Kurz gefasst
Fachartikel in der Zeitschrift iMeta, online erschienen am 20.08.2026. Verfasst von Yunhong Shi und 12 weiteren Autor:innen. Beteiligte Einrichtung: Guangdong Eye Institute, Department of Ophthalmology, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences) Southern Medical…. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Retinal ischemia‐reperfusion (RIR) injury is a central mechanism underlying irreversible vision loss in glaucoma and other retinal diseases, yet the spatial organization of the pathogenic microenvironment remains poorly understood. Here, we constructed a high‐resolution, whole‐eye spatial multi‐omics atlas integrating Stereo‐seq transcriptomics and MALDI‐MSI‐based metabolomics to capture the early molecular events in the RIR mouse model. Spatially, retinal ganglion cell (RGC) interactions with surrounding cells were markedly reduced after injury, whereas immune–glial interactions were enhanced, revealing a shift from a neuron‐centered to an immunometabolic state. Within the ganglion cell layer (GCL), the primary pathological locus, we identified Trem2 + microglia that expand in situ, establish close proximity to degenerating RGCs, and exhibit strong spatial association with dysregulated sphingolipid metabolism. Mechanistically, using Trem2 knockout mice and microglia‐specific Trem2 siRNA knockdown, we demonstrate that TREM2 directly binds to SPTLC2, the rate‐limiting enzyme of de novo sphingolipid biosynthesis, driving ceramide‐centric metabolic reprogramming that modulates the AKT‐mTOR signaling axis and amplifies inflammatory activation. Pharmacological inhibition of serine palmitoyl transferase (SPT) with myriocin reverses this cascade, protecting RGCs. Multi‐omics integration of human glaucoma aqueous humor datasets further reveals conserved upregulation of sphingolipid biosynthetic enzymes, sphingolipid metabolites, and lipid‐sensing immune effectors, offering preliminary translational clues. Collectively, our findings reveal that spatially defined immunometabolic remodeling—in which Trem2 + microglia are central—converges on sphingolipid metabolism as a druggable regulatory axis, with the TREM2‐SPTLC2 interface thus emerging as a new therapeutic opportunity for retinal neurodegenerative diseases.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Guangdong Eye Institute, Department of Ophthalmology, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences) Southern Medical University Guangzhou China.
- State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center Sun Yat-sen University, Guangdong Provincial Key Laboratory of Ophthalmology Visual Science Guangzhou China.
- College of Life Sciences University of Chinese Academy of Sciences Beijing China.
- Analysis Center of Agrobiology and Environmental Sciences Zhejiang University Hangzhou China.
- Shenzhen Eye Hospital, Shenzhen Eye Medical Center Southern Medical University Shenzhen China.
- Department of Eye and Vision Sciences, Institute of Life Course and Medical Sciences University of Liverpool Liverpool UK.
ORCID-Profile: Yunhong Shi, Jinpei Lin
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Shi, Y., Lin, J., Wu, Y., Xu, S., Zhang, N., Pan, Y., Ren, A., Fang, Y., Huang, Y., Zhang, X., Zhu, Z., Zhuo, Y., & Yu, H. (2026). Spatial multi‐omics unveils sphingolipid metabolic reprogramming within the retinal pathological niche. iMeta, 5(4). https://doi.org/10.1002/imt2.70163
Vancouver
Shi Y, Lin J, Wu Y, Xu S, Zhang N, Pan Y, et al. Spatial multi‐omics unveils sphingolipid metabolic reprogramming within the retinal pathological niche. iMeta. 2026;5(4). doi:10.1002/imt2.70163
BibTeX
@article{Shi2026,
author = {Shi, Yunhong and Lin, Jinpei and Wu, Yi and Xu, Shengsong and Zhang, Naiyuan and Pan, Yiji and Ren, Anli and Fang, Ying and Huang, Yu and Zhang, Xiayin and Zhu, Zhuoting and Zhuo, Yehong and Yu, Honghua},
title = {Spatial multi‐omics unveils sphingolipid metabolic reprogramming within the retinal pathological niche},
journal = {iMeta},
year = {2026},
volume = {5},
number = {4},
doi = {10.1002/imt2.70163}
}
EUVIMED